Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab

Purpose: The tumor-infiltrating lymphocytes (TILs) expression in breast cancer is a positive prognostic marker for certain breast cancer subtypes. We evaluated the efficacy of dual antihuman epidermal growth factor receptor 2 (HER2) blockade in HER2-positive breast cancer and hypothesized that high...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of breast cancer 2021, 24(4), 102, pp.359-366
Hauptverfasser:	Ha, Joo Young, Kim, Jeong Eun, Lee, Hee Jin, Jeong, Jae Ho, Ahn, Jin-Hee, Jung, Kyung Hae, Gong, Gyungyub, Chae, Eun Young, Kim, Hak Hee, Chung, Il Yong, Ko, Beom Seok, Kim, Sung-Bae
Format:	Artikel
Sprache:	eng
Schlagworte:	Life Sciences & Biomedicine Oncology Original Science & Technology 일반외과학
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!